Comparison of the efficacies of oral β-lactams in selection of Haemophilus influenzae transformants with mutated ftsI genes

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 5, 2008, Pages 1880-1883

  Takahata, Sho ^a   Kato, Yoshihisa ^a   Sanbongi, Yumiko ^a   Maebashi, Kazunori ^a   Ida, Takashi ^a  

^a MEIJI SEIKA KAISHA LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFCAPENE; CEFDINIR; CEFDITOREN; CEFPODOXIME; CEFPROZIL; CEFUROXIME; TEBIPENEM;

ARTICLE; DRUG EFFICACY; FTSI GENE; GENE; GENE TRANSFER; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL;

AMPICILLIN; BACTERIAL PROTEINS; BETA-LACTAMS; CARBAPENEMS; CEPHALOSPORINS; GENE TRANSFER, HORIZONTAL; HAEMOPHILUS INFLUENZAE; MUTATION; PENICILLIN-BINDING PROTEINS;

EID: 42949144816     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00936-07     Document Type: Article

References (22)

1. Blosser-Middleton, R., D. F. Sahm, C. Thornsberry, M. E. Jones, P. A. Hogan, I. A. Critchley, and J. A. Karlowsky. 2003. Antimicrobial susceptibility of 840 clinical isolates of Haemophilus influenzae collected in four European countries in 2000-2001. Clin. Microbiol. Infect. 9:431-436.
2. Brown, S. D., and M. J. Rybak. 2004. Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study. J. Antimicrob. Chemother. 54(Suppl. 1):i7-i15.
3. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Dabernat, H., C. Delmas, M. Seguy, R. Pelissier, G. Faucon, S. Bennamani, and C. Pasquier. 2002. Diversity of β-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob. Agents Chemother. 46:2208-2218.
5. García-Cobos, S., J. Campos, E. Lázaro, F. Román, E. Cercenado, C. García-Rey, M. Pérez-Vázquez, J. Oteo, and F. de Abajo. 2007. Ampicillin-resistant non-β-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. Antimicrob. Agents Chemother. 51:2564-2573.
6. Gazagne, L., C. Delmas, E. Bingen, and H. Dabernat. 1998. Molecular epidemiology of ampicillin-resistant non-β-lactamase-producing Haemophilus influenzae. J. Clin. Microbiol. 36:3629-3635.
7. Hasegawa, K., K. Yamamoto, N. Chiba, R. Kobayashi, K. Nagai, M. R. Jacobs, P. C. Appelbaum, K. Sunakawa, and K. Ubukata. 2003. Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States. Microb. Drug Resist. 9:39-46.
8. Hikida, M., K. Itahashi, A. Igarashi, T. Shiba, and M. Kitamura. 1999. In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity. Antimicrob. Agents Chemother. 43:2010-2016.
9. Hotomi, M., K. Fujihara, A. Sakai, D. S. Billal, J. Shimada, M. Suzumoto, and N. Yamanaka. 2006. Antimicrobial resistance of Haemophilus influenzae isolated from the nasopharynx of Japanese children with acute otitis media. Acta Otolaryngol. 126:240-247.
10. Jacobs, M. R., D. Felmingham, P. C. Appelbaum, R. N. Gruneberg, and the Alexander Project Group. 2003. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J. Antimicrob. Chemother. 52:229-246.
11. Jansen, W. T. M., A. Verel, M. Beitsma, J. Verhoef, and D. Milatovic. 2006. Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae. J. Antimicrob. Chemother. 58:873-877.
12. Karlowsky, J. A., I. A. Critchley, R. S. Blosser-Middleton, E. A. Karginova, M. E. Jones, C. Thornsberry, and D. F. Sahm. 2002. Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a β-lactamase- negative and ampicillin-resistant strain. J. Clin. Microbiol. 40:1063-1066.
13. Kim, I.-S., C.-S. Ki, S. Kim, W. S. Oh, K. R. Peck, J.-H. Song, K. Lee, and N. Y. Lee. 2007. Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolated in Korea. Antimicrob. Agents Chemother. 51:453-460.
14. Miyazaki, S., T. Hosoyama, N. Furuya, Y. Ishii, T. Matsumoto, A. Ohno, K. Tateda, and K. Yamaguchi. 2001. In vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections. Antimicrob. Agents Chemother. 45:203-207.
15. Osaki, Y., Y. Sanbongi, M. Ishikawa, H. Kataoka, T. Suzuki, K. Maeda, and T. Ida. 2005. Genetic approach to study the relationship between penicillin-binding protein 3 mutations and Haemophilus influenzae β-lactam resistance by using site-directed mutagenesis and gene recombinants. Antimicrob. Agents Chemother. 49:2834-2839.
16. Peric, M., F. A. Browne, M. R. Jacobs, and P. C. Appelbaum. 2003. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/ pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents. Clin. Ther. 25:169-177.
17. Sanbongi, Y., T. Suzuki, Y. Osaki, N. Senju, T. Ida, and K. Ubukata. 2006. Molecular evolution of β-lactam-resistant Haemophilus influenzae: 9-year surveillance of penicillin-binding protein 3 mutations in isolates from Japan. Antimicrob. Agents Chemother. 50:2487-2492.
18. Suzuki, K., T. Nishimura, and S. Baba. 2003. Current status of bacterial resistance in the otolaryngology field: results from the second nationwide survey in Japan. J. Infect. Chemother. 9:46-52.
19. Takahata, S., T. Ida, N. Senju, Y. Sanbongi, A. Miyata, K. Maebashi, and S. Hoshiko. 2007. Horizontal gene transfer of ftsI, encoding penicillin-binding protein 3, in Haemophilus influenzae. Antimicrob. Agents Chemother. 51:1589-1595.
20. Tristram, S., M. R. Jacobs, and P. C. Appelbaum. 2007. Antimicrobial resistance in Haemophilus influenzae. Clin. Microbiol. Rev. 20:368-389.
21. Ubukata, K., Y. Shibasaki, K. Yamamoto, N. Chiba, K. Hasegawa, Y. Takeuchi, K. Sunakawa, M. Inoue, and M. Konno. 2001. Association of amino acid substitutions in penicillin-binding protein 3 with β-lactam resistance in β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob. Agents Chemother. 45:1693-1699.
22. Watanabe, H., K. Hoshino, R. Sugita, N. Asoh, K. Watanabe, K. Oishi, and T. Nagatake. 2004. Possible high rate of transmission of nontypeable Haemophilus influenzae, including β-lactamase-negative ampicillin-resistant strains, between children and their parents. J. Clin. Microbiol. 42:362-365.